prepopik- sodium picosulfate, magnesium oxide, and anhydrous citric acid powder, metered
ferring pharmaceuticals inc. - sodium picosulfate (unii: lr57574hn8) (deacetylbisacodyl - unii:r09078e41y), magnesium oxide (unii: 3a3u0gi71g) (magnesium cation - unii:t6v3lhy838), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl) - sodium picosulfate 10 mg in 16.1 g - prepopik® is indicated for cleansing of the colon as a preparation for colonoscopy in adults and pediatric patients 9 years of age and older. prepopik is contraindicated in the following conditions: - patients with severe renal impairment (creatinine clearance less than 30 ml/minute) which may result in accumulation of magnesium [see warnings and precautions (5.4)] - gastrointestinal obstruction or ileus [see warnings and precautions (5.6)] - bowel perforation [see warnings and precautions (5.6)] - toxic colitis or toxic megacolon - gastric retention - hypersensitivity to any of the ingredients in prepopik [see adverse reactions (6.2)] risk summary there are no data with prepopik use in pregnant women to determine a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in an animal reproduction study, no adverse developmental effects were observed in pregnant rats when sodium picosulfate, magnesium oxide, and anhydrous citric acid were administered orally at doses 1
sodium chloride irrigant
cardinal health - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37) - sodium chloride 0.9 g in 100 ml
sodium chloride 0.3 % w/v and glucose 3.3% w/v solution for infusion bp
baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.3/ 3.3 percent weight/volume - salt solutions; sodium chloride
sodium chloride 0.45 % w/v and glucose 2.5% w/v solution for infusion bp
baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.45/2.5 percent weight/volume - salt solutions; sodium chloride
sodium chloride 0.45% w/v solution for infusion
baxter holding b.v. - sodium chloride - solution for infusion - 0.45 percent weight/volume - electrolyte solutions; sodium chloride
sodium chloride 0.9 % w/v and glucose 5% w/v solution for infusion bp (viaflo container)
baxter holding b.v. - sodium chloride; glucose - solution for infusion - 0.9/5 percent weight/volume - salt solutions; sodium chloride
sodium chloride intravenous infusion bp 0.9% w/v (viaflex container)
baxter holding b.v. - sodium chloride - solution for infusion - 0.9 percent weight/volume - electrolyte solutions; sodium chloride
sodium chloride 0.9 % w/v solution for infusion
fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - electrolyte solutions; sodium chloride
sodium chloride 0.9% w/v solution for infusion, polyethylene bottle
fresenius kabi deutschland gmbh - sodium chloride - solution for infusion - 0.9 percent weight/volume - electrolyte solutions; sodium chloride
sodium chloride 0.9% w/v solvent for parenteral use
fresenius kabi deutschland gmbh - sodium chloride - solvent for parenteral use - 0.9 %v/w - electrolyte solutions; sodium chloride